Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
American National Group, Inc is an insurance-diversified business based in the US. American National Group shares (ANAT) are listed on the NASDAQ and all prices are listed in US Dollars.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced investors
52-week range | USD$61.996 - USD$99.68 |
---|---|
50-day moving average | USD$93.0703 |
200-day moving average | USD$82.5919 |
Wall St. target price | USD$87.04 |
PE ratio | 7.5945 |
Dividend yield | USD$3.28 (3.57%) |
Earnings per share (TTM) | USD$12.351 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing American National Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of American National Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
American National Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, American National Group shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
American National Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$452.5 million.
The EBITDA is a measure of a American National Group's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | USD$3.7 billion |
---|---|
Operating margin TTM | 10.95% |
Gross profit TTM | USD$1.2 billion |
Return on assets TTM | 0.86% |
Return on equity TTM | 5.56% |
Profit margin | 9.08% |
Book value | $228.689 |
Market capitalisation | USD$2.5 billion |
TTM: trailing 12 months
There are currently 52,690 American National Group shares held short by investors – that's known as American National Group's "short interest". This figure is 14.2% down from 61,394 last month.
There are a few different ways that this level of interest in shorting American National Group shares can be evaluated.
American National Group's "short interest ratio" (SIR) is the quantity of American National Group shares currently shorted divided by the average quantity of American National Group shares traded daily (recently around 25702.43902439). American National Group's SIR currently stands at 2.05. In other words for every 100,000 American National Group shares traded daily on the market, roughly 2050 shares are currently held short.
However American National Group's short interest can also be evaluated against the total number of American National Group shares, or, against the total number of tradable American National Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case American National Group's short interest could be expressed as 0% of the outstanding shares (for every 100,000 American National Group shares in existence, roughly 0 shares are currently held short) or 0.0085% of the tradable shares (for every 100,000 tradable American National Group shares, roughly 9 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against American National Group.
Find out more about how you can short American National Group stock.
Dividend payout ratio: 15.96% of net profits
Recently American National Group has paid out, on average, around 15.96% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.54% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), American National Group shareholders could enjoy a 3.54% return on their shares, in the form of dividend payments. In American National Group's case, that would currently equate to about $3.28 per share.
While American National Group's payout ratio might seem low, this can signify that American National Group is investing more in its future growth.
American National Group's most recent dividend payout was on 19 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 5 March 2021 (the "ex-dividend date").
Over the last 12 months, American National Group's shares have ranged in value from as little as $61.996 up to $99.68. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while American National Group's is 0.8138. This would suggest that American National Group's shares are less volatile than average (for this exchange).
American National Group, Inc. provides life insurance, annuities, property and casualty insurance, health insurance, credit insurance, and pension products in the United States, the District of Columbia, and Puerto Rico. It offers whole life, term life, universal life, variable universal life, and credit life insurance products. The company also provides deferred, variable, and single premium immediate annuity products; and medicare supplement, supplemental, stop-loss, credit disability, and medical expense insurance products. In addition, it offers personal lines insurance, such as auto, homeowners, boats, motorcycles, recreational vehicles, and other exposures; and commercial lines of insurance, including property and casualty coverage tailored for a farm, ranch, or other agricultural business within the rural and suburban markets, as well as business owners, property, liability, mortgage security insurance, and workers' compensation coverages. Further, the company provides credit-related property insurance products comprising collateral or creditor protection insurance; and guaranteed auto protection or guaranteed asset protection insurance. Additionally, it engages in the investment activities. The company distributes its products through career and multiple-line agents, broker-dealers, independent insurance agents and brokers, managing general underwriters, marketing organizations, employee benefit firms, and financial institutions, as well as through direct marketing channels and call centers. American National Group, Inc. was founded in 1905 and is based in Galveston, Texas.
Everything we know about the Reddit IPO, plus information on how to buy in.
Everything we know about the Hayward Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Alignment Healthcare Inc IPO, plus information on how to buy in.
Everything we know about the Olink Holding AB (publ) IPO, plus information on how to buy in.
Everything we know about the Procore IPO, plus information on how to buy in.
Everything we know about the Navios South American Logistics Inc IPO, plus information on how to buy in.
Everything we know about the Lava Therapeutics IPO, plus information on how to buy in.
Everything we know about the Pop Culture Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Bukalapak IPO, plus information on how to buy in.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.